capsitec GmbH
puts viruses in quarantine
There is no effective treatment or cure for more than 70% of all WHO-listed viruses. As a result, millions of people suffer from viral infections every year, causing numerous cases of death and enormous economic damage.
Being a spin-off from the Technical University Munich, capsitec GmbH develops a generic antiviral platform with the aim to combat many different viral diseases using DNA nanotechnology.
Their antiviral technology relies on programmable artificial DNA nano-shells that are large enough to encapsulate entire viruses. Once a virus is trapped inside a nano-shell, the virus is neutralized. The nano-shells are highly modular and can be easily programmed to target many different viral pathogens, thus forming the basis for a generic antiviral platform.
By loading the video, you agree to YouTube’s privacy policy.
Learn more
Kontakt
Christian Sigl
Mail: christian@capsitec.com
Keyfacts
